Oncology and Advanced Solid Tumors
Clinical research includes studies in metastatic and locally advanced tumors, with interest in treatments for advanced cancer across difficult-to-treat tumor settings.
- Metastatic tumors
- Locally advanced cancer
- Solid tumor oncology
The oncology portfolio reflects a focus on therapeutic options for patients with progressive malignancies and limited treatment alternatives.
Kidney Disease and Polycystic Kidney Disease
Research activity also covers autosomal dominant polycystic kidney disease, a genetic disorder associated with progressive renal involvement and long-term kidney function decline.
- Autosomal dominant polycystic kidney disease
- Renal cystic disease
- Chronic kidney disease
This area centers on therapies relevant to inherited kidney disorders and associated renal complications.
Rare Neurological Disorders
Clinical studies include vanishing white matter disease, a rare leukodystrophy affecting the central nervous system and neurological function in both adult and pediatric populations.
- Vanishing white matter disease
- Leukodystrophy
- Pediatric neurology
Research in this field is directed toward rare neurodegenerative conditions with substantial unmet medical need.
Genetic and Molecular Therapeutics
The sponsor’s pipeline spans therapies aimed at genetic disease mechanisms and molecularly targeted approaches, including programs relevant to inherited and oncology-related conditions.
- Genetic disorders
- Molecular targeting
- Translational medicine
This therapeutic scope links rare disease research with precision-oriented treatment development.
